Market intelligence, trend analysis and forecasts for the Pharma and Healthcare industries across the regions

Industry / Brazil

Cervical Cancer Programmes Receive Funding Boost

September 2011 | Industry Trend Analysis

BMI View: While most developed countries have incorporated some form of the human papillomavirus (HPV) vaccine into their national cervical cancer strategy, we believe Brazil's emphasis on public screening - not prevention - is driven by a desire to source a vaccine variant that is more suitable and cost effective to the country's healthcare needs.

To read the full article, please choose one of the following options:

Subcribers please log in